ASPP Proteins Specifically Stimulate the Apoptotic Function of p53

Antibodies, a laboratory manual

(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,318

p53: puzzle and paradigm.Preprint

Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346

Structure of the p53 Tumor Suppressor Bound to the Ankyrin and SH3 Domains of 53BP2

Gorina, S. S., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.1001 · Cited by 575

Two cellular proteins that bind to wild-type but not mutant p53.

Iwabuchi, K., Bartel, P. L., Li, B., Marraccino, R. L., & Fields, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.6098 · Cited by 432

In vivo gene expression profile analysis of human breast cancer progression.

Sgroi, D. C., Teng, S., ROBINSON, G. C., LeVangie, R., Hudson, J. R., & Elkahloun, A. G. (1999) · PubMed · Cited by 390

Differential Activation of Target Cellular Promoters by p53 Mutants with Impaired Apoptotic Function

Ludwig, R. L., Bates, S., & Vousden, K. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4952 · Cited by 278

E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction.Preprint

Hsieh, J.-K., Fredersdorf, S., Kouzarides, T., Martin, K., & Lü, X. (1997) · Genes & Development · doi:10.1101/gad.11.14.1840 · Cited by 278

A Mutant p53 That Discriminates between p53-Responsive Genes Cannot Induce Apoptosis

Friedlander, P. A., Haupt, Y., Prives, C. L., & Oren, M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4961 · Cited by 277

Stimulation of p53-mediated Transcriptional Activation by the p53-binding Proteins, 53BP1 and 53BP2

Iwabuchi, K., Li, B., Massa, H. F., Trask, B. J., Date, T., & Fields, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.26061 · Cited by 206

p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours

Crook, T., Brooks, L. A., Crossland, S., Osin, P., Barker, K. T., Waller, J., Philp, E., Smith, P. D., Yuluğ, I. G., Peto, J., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1202106 · Cited by 179

ASPP2 Binds Par-3 and Controls the Polarity and Proliferation of Neural Progenitors during CNS Development

Sottocornola, R., Royer, C., Vives, V., Tordella, L., Zhong, S., Wang, Y., Ratnayaka, I., Shipman, M., Cheung, A. F. P., Gaston‐Massuet, C., et al. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.06.003 · Cited by 121

Mechanisms of regulatory diversity within the p53 transcriptional network

Espinosa, J. M. (2008) · Oncogene · doi:10.1038/onc.2008.37 · Cited by 115

Autophagic activity dictates the cellular response to oncogenic RAS

Wang, Y., Wang, X. D., Lapi, E., Sullivan, A., Jia, W., He, Y.-W., Ratnayaka, I., Zhong, S., Goldin, R. D., Goemans, C. G., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120193109 · Cited by 117

p53: Twenty five years understanding the mechanism of genome protection

Gómez-Lázaro, M., Fernández-Gómez, F.-J., & Jordán, J. (2004) · Journal of Physiology and Biochemistry · doi:10.1007/bf03167075 · Cited by 119

Mutant p53 targeting by the low molecular weight compound STIMA‐1

Zache, N., Lambert, J. M. R., Rökaeus, N., Shen, J., Hainaut, P. L., Bergman, J., Wiman, K. G., & Bykov, V. J. N. (2008) · Molecular Oncology · doi:10.1016/j.molonc.2008.02.004 · Cited by 120

p53 downstream target genes and tumor suppression: a classical view in evolution

Rozan, L. M., & El‐Deiry, W. S. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402058 · Cited by 118

DNA Binding Cooperativity of p53 Modulates the Decision between Cell-Cycle Arrest and Apoptosis

Schlereth, K., Beinoraviciute-Kellner, R., Zeitlinger, M. K., Bretz, A. C., Sauer, M., Charles, J. P., Vogiatzi, F., Leich, E., Samans, B., Eilers, M., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.037 · Cited by 113

Cytoplasmic ASPP1 inhibits apoptosis through the control of YAPPreprint

Vigneron, A. M., Ludwig, R. L., & Vousden, K. H. (2010) · Genes & Development · doi:10.1101/gad.1954310 · Cited by 115

Pharmacogenomic Discovery Using Cell-Based Models

Welsh, M. M., Mangravite, L. M., Medina, M. W., Tantisira, K. G., Zhang, W., Huang, R. S., McLeod, H. L., & Dolan, M. E. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001461 · Cited by 113

E2F1-induced apoptosis: turning killers into therapeutics

Stanelle, J., & Pützer, B. M. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.02.002 · Cited by 112

p53-mediated apoptosis requires inositol hexakisphosphate kinase-2

Koldobskiy, M. A., Chakraborty, A., Werner, J. K., Snowman, A. M., Juluri, K. R., Vandiver, M. S., Kim, S., Heletz, S., & Snyder, S. H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015671107 · Cited by 112

The C Terminus of p53 Family Proteins Is a Cell Fate Determinant

Harms, K. L., & Chen, X. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.5.2014-2030.2005 · Cited by 109

Epigenetic Silence of Ankyrin-Repeat–Containing, Sh3-Domain–Containing, and Proline-Rich-Region– Containing Protein 1 ( Aspp1 ) and Aspp2 Genes Promotes Tumor Growth in Hepatitis B Virus–Positive Hepatocellular Carcinoma

Zhao, J., Wu, G., Bu, F., Lü, B., Liang, A., Cao, L., Tong, X., Lü, X., Wu, M., & Guo, Y. (2009) · Hepatology · doi:10.1002/hep.23247 · Cited by 109

p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.

Phelps, M., Darley, M., Primrose, J. N., & Blaydes, J. P. (2003) · PubMed · Cited by 109

Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F

Hershko, T., Chaussepied, M., Oren, M., & Ginsberg, D. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401575 · Cited by 107

Genetic polymorphisms and treatment response in advanced non-small cell lung cancer

Su, D., Ma, S., Liu, P., Jiang, Z., Lv, W., Zhang, Y., Deng, Q., Smith, S., & Yu, H. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2006.12.002 · Cited by 106

Regulation of p53 - insights into a complex process

Boehme, K. A., & Blattner, C. (2009) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409230903401507 · Cited by 107

ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growthPreprint

Vives, V., Su, J., Zhong, S., Ratnayaka, I., Slee, E. A., Goldin, R. D., & Lü, X. (2006) · Genes & Development · doi:10.1101/gad.374006 · Cited by 105

Zbtb4 represses transcription of P21CIP1 and controls the cellular response to p53 activation

Weber, A., Marquardt, J., Elzi, D. J., Forster, N., Starke, S., Glaum, A., Yamada, D., Defossez, P., Delrow, J. J., Eisenman, R. N., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.85 · Cited by 104

Structural evolution of C‐terminal domains in the p53 family

Ou, H. D., Löhr, F., Vogel, V., Mäntele, W., & Dötsch, V. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601764 · Cited by 108

Molecular biology of cantharidin in cancer cells

Rauh, R., Kahl, S., Boechzelt, H. G., Bauer, R., Kaina, B., & Efferth, T. (2007) · Chinese Medicine · doi:10.1186/1749-8546-2-8 · Cited by 101

Regulation of the p53 transcriptional activity

Liu, G., & Chen, X. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20700 · Cited by 100

The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1Preprint

Aylon, Y., Ofir-Rosenfeld, Y., Yabuta, N., Lapi, E., Nojima, H., Lü, X., & Oren, M. (2010) · Genes & Development · doi:10.1101/gad.1954410 · Cited by 100

CagA-mediated pathogenesis of Helicobacter pylori

Tohidpour, A. (2016) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.01.005 · Cited by 100

Oxidized DJ-1 Inhibits p53 by Sequestering p53 from Promoters in a DNA-Binding Affinity-Dependent Manner

Kato, I., Maita, H., Takahashi-Niki, K., Saito, Y., Noguchi, N., Iguchi‐Ariga, S. M. M., & Ariga, H. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.01350-12 · Cited by 98

CHOP mediates ASPP2-induced autophagic apoptosis in hepatoma cells by releasing Beclin-1 from Bcl-2 and inducing nuclear translocation of Bcl-2

Liu, K., Shi, Y., Guo, X., Wang, S., Ouyang, Y., Hao, M., Liu, D., Qiao, L., Li, N., Zheng, J., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.276 · Cited by 99

A new p38 MAP kinase‐regulated transcriptional coactivator that stimulates p53‐dependent apoptosis

Cuadrado, A., Lafarga, V., Cheung, P., Dolado, I., Llanos, S., Cohen, P., & Nebreda, Á. R. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601657 · Cited by 101

p53 pulses lead to distinct patterns of gene expression albeit similar DNA-binding dynamics

Hafner, A., Stewart-Ornstein, J., Purvis, J. E., Forrester, W. C., Bulyk, M. L., & Lahav, G. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3452 · Cited by 94

Regulation of the p14ARF-Mdm2-p53 pathway: An overview in breast cancer

Agrawal, A., Yang, J., Murphy, R. F., & Agrawal, D. K. (2006) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2006.07.001 · Cited by 95

Some p53-binding proteins that can function as arbiters of life and death

Braithwaite, A. W., Sal, G. D., & Lü, X. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401924 · Cited by 96

Isolation of Temperature-sensitive p53 Mutations from a Comprehensive Missense Mutation Library

Shiraishi, K., Kato, S., Han, S., Liu, W., Otsuka, K., Sakayori, M., Ishida, T., Takeda, M., Kanamaru, R., Ohuchi, N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310815200 · Cited by 95

Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage

Ozaki, T., Wu, D., Sugimoto, H., Nagase, H., & Nakagawara, A. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.127 · Cited by 92

Death-associated Protein 4 Binds MST1 and Augments MST1-induced Apoptosis

Lin, Y., Khokhlatchev, A. V., Figeys, D., & Avruch, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202630200 · Cited by 92

Gene-specific repression of the p53 target gene PUMA via intragenic CTCF–Cohesin bindingPreprint

Gomes, N. P., & Espinosa, J. M. (2010) · Genes & Development · doi:10.1101/gad.1881010 · Cited by 94

Characterization of the p53 Cistrome – DNA Binding Cooperativity Dissects p53's Tumor Suppressor Functions

Schlereth, K., Heyl, C., Krampitz, A.-M., Mernberger, M., Finkernagel, F., Scharfe, M., Jarek, M., Leich, E., Rosenwald, A., & Stiewe, T. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003726 · Cited by 87

NAD+ Modulates p53 DNA Binding Specificity and Function

McLure, K. G., Takagi, M., & Kastan, M. B. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.22.9958-9967.2004 · Cited by 89

Vascular aging: Molecular mechanisms and potential treatments for vascular rejuvenation

Mistriotis, P., & Andreadis, S. T. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.05.006 · Cited by 89

Restoration of wild‐type p53 function in human cancer: Relevance for tumor therapy

Bossi, G., & Sacchi, A. (2007) · Head & Neck · doi:10.1002/hed.20529 · Cited by 86

Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressorPreprint

Stegh, A. H., Brennan, C., Mahoney, J. E., Forloney, K. L., Jenq, H. T., Luciano, J. P., Protopopov, A. I., Chin, L., & DePinho, R. A. (2010) · Genes & Development · doi:10.1101/gad.1924710 · Cited by 88

Versatile functions of p53 protein in multicellular organisms

Chumakov, P. M. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907130019 · Cited by 85

Global dissociation of HuR–mRNA complexes promotes cell survival after ionizing radiation

Masuda, K., Abdelmohsen, K., Kim, M. M., Srikantan, S., Lee, E. K., Tominaga, K., Selimyan, R., Martindale, J. L., Yang, X., Lehrmann, E., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.24 · Cited by 85

Biochemical and Structural Studies of ASPP Proteins Reveal Differential Binding to p53, p63, and p73

Robinson, R. A., Lü, X., Jones, E. Y., & Siebold, C. (2008) · Structure · doi:10.1016/j.str.2007.11.012 · Cited by 82

Transcriptional Response to Acute Thermal Exposure in Juvenile Chinook Salmon Determined by RNAseq

Tomalty, K. M. H., Meek, M. H., Stephens, M. R., Rincón, G., Fangue, N. A., May, B. P., & Baerwald, M. R. (2015) · G3 Genes Genomes Genetics · doi:10.1534/g3.115.017699 · Cited by 86

Quantitative comparison of the fasted and re-fed mouse liver phosphoproteomes using lower pH reductive dimethylation

Wilson‐Grady, J., Haas, W., & Gygi, S. P. (2013) · Methods · doi:10.1016/j.ymeth.2013.03.031 · Cited by 80

Therapeutic targeting of p53 by small molecules

Selivanova, G. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.02.006 · Cited by 84

p53, apoptosis and axon-guidance molecules

Arakawa, H. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401601 · Cited by 86

The biological impact of the human master regulator p53 can be altered by mutations that change the spectrum and expression of its target genes

Menendez, D., Inga, A., & Resnick, M. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2297-2308.2006 · Cited by 81

A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo

Bell, H. S., Dufès, C., O’Prey, J., Crighton, D., Bergamaschi, D., Lü, X., Schätzlein, A. G., Vousden, K. H., & Ryan, K. M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28920 · Cited by 80

Retrograde signaling from autophagy modulates stress responses

Simon, H., Friis, R. R., Tait, S. W. G., & Ryan, K. M. (2017) · Science Signaling · doi:10.1126/scisignal.aag2791 · Cited by 79

The Transcriptional Repressor hDaxx Potentiates p53-dependent Apoptosis

Gostissa, M., Morelli, M., Mantovani, F., Guida, E., Piazza, S., Collavin, L., Brancolini, C., Schneider, C., & Sal, G. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310801200 · Cited by 79

A Code for RanGDP Binding in Ankyrin Repeats Defines a Nuclear Import Pathway

Lu, M. M., Žák, J., Chen, S., Sánchez‐Pulido, L., Severson, D. T., Endicott, J., Ponting, C. P., Schofield, C. J., & Lü, X. (2014) · Cell · doi:10.1016/j.cell.2014.05.006 · Cited by 76

The Role of microRNA-21 in the Onset and Progression of Cancer

Singh, A. K., Singh, A. K., Giri, R., Kumar, D., Sharma, R., Vališ, M., Kuča, K., & Garg, N. (2021) · Future Medicinal Chemistry · doi:10.4155/fmc-2021-0096 · Cited by 81

p53 apoptotic pathway molecules are frequently and simultaneously altered in nonsmall cell lung carcinoma

Mori, S., Ito, G., Usami, N., Yoshioka, H., Ueda, Y., Kodama, Y., Takahashi, M., Fong, K. M., Shimokata, K., & Sekido, Y. (2004) · Cancer · doi:10.1002/cncr.20164 · Cited by 76

What have animal models taught us about the p53 pathway?

Lozano, G., & Zambetti, G. P. (2005) · The Journal of Pathology · doi:10.1002/path.1704 · Cited by 78

Head and neck tumor sites differ in prevalence and spectrum of p53 alterations but these have limited prognostic value

Bosch, F. X., Ritter, D., Enders, C., Flechtenmacher, C., Abel, U. R., Dietz, A., Hergenhahn, M., & Weidauer, H. (2004) · International Journal of Cancer · doi:10.1002/ijc.11698 · Cited by 75

Cell and tissue responses to genotoxic stress

Coates, P. J., Lorimore, S. A., & Wright, E. G. (2005) · The Journal of Pathology · doi:10.1002/path.1701 · Cited by 77

RNA content in the nucleolus alters p53 acetylation via MYBBP1A

Kuroda, T., Murayama, A., Katagiri, N., Ohta, Y., Fujita, E., Masumoto, H., Ema, M., Takahashi, S., Kimura, K., & Yanagisawa, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.23 · Cited by 77

A positive feedback mechanism in the transcriptional activation of Apaf-1 by p53 and the coactivator Zac-1

Rozenfeld-Granot, G., Krishnamurthy, J., Kannan, K., Toren, A., Amariglio, N., Givol, D., & Rechavi, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205218 · Cited by 72

Whole-genome cartography of p53 response elements ranked on transactivation potential

Tebaldi, T., Zaccara, S., Alessandrini, F., Bisio, A., Ciribilli, Y., & Inga, A. (2015) · BMC Genomics · doi:10.1186/s12864-015-1643-9 · Cited by 72

TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next Decade

Soussi, T. (2011) · Advances in cancer research · doi:10.1016/b978-0-12-386469-7.00005-0 · Cited by 77

iASPP and Chemoresistance in Ovarian Cancers: Effects on Paclitaxel-Mediated Mitotic Catastrophe

Jiang, L., Siu, M. K. Y., Wong, O. G., Tam, K.-F., Lü, X., Lam, E. W. ‐., Ngan, H., Le, X., Wong, E. S. Y., Monteiro, L. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0588 · Cited by 75

The p53 response: Emerging levels of co-factor complexity

Coutts, A. S., & La Thangue, N. B. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.150 · Cited by 72

Coordination between Cell Cycle Progression and Cell Fate Decision by the p53 and E2F1 Pathways in Response to DNA Damage

Zhang, X. P., Liu, F., & Wang, W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.134650 · Cited by 73

Regulation of p53 by TopBP1: a Potential Mechanism for p53 Inactivation in Cancer

Liu, K., Bellam, N., Lin, H., Wang, B., Stockard, C. R., Grizzle, W. E., & Lin, W.-C. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01140-08 · Cited by 70

TP53 mutations in familial breast cancer: Functional aspects

Gasco, M., Yuluğ, I. G., & Crook, T. (2003) · Human Mutation · doi:10.1002/humu.10173 · Cited by 71

Apoptosis and Tumor Cell Death in Response to HAMLET (Human α-Lactalbumin Made Lethal to Tumor Cells)

Hällgren, O., Aits, S., Brest, P., Gustafsson, L., Mossberg, A., Wullt, B., & Svanborg, C. (2007) · Springer eBooks · doi:10.1007/978-0-387-74087-4_8 · Cited by 71

Boswellic acid induces epigenetic alterations by modulating DNA methylation in colorectal cancer cells

Shen, Y., Takahashi, M., Byun, H., Link, A., Sharma, N., Balaguer, F., Leung, H.-C., Boland, C. R., & Goel, A. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.19604 · Cited by 70

lncRNA MEG3 had anti-cancer effects to suppress pancreatic cancer activity

Gu, L., Zhang, J., Shi, M., Zhan, Q., Shen, B., & Peng, C. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.02.041 · Cited by 70

p53: a heavily dictated dictator of life and death

Lü, X. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.008 · Cited by 69

Requirement of clathrin heavy chain for p53-mediated transcriptionPreprint

Enari, M., Ohmori, K., Kitabayashi, I., & Taya, Y. (2006) · Genes & Development · doi:10.1101/gad.1381906 · Cited by 71

Brn-3a Transcription Factor Blocks p53-mediated Activation of Proapoptotic Target Genes Noxa and Bax in Vitro and in Vivo to Determine Cell Fate

Hudson, C. D., Morris, P. J., Latchman, D. S., & Budhram-Mahadeo, V. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408679200 · Cited by 68

Runt-related Transcription Factor 1 (RUNX1) Stimulates Tumor Suppressor p53 Protein in Response to DNA Damage through Complex Formation and Acetylation

Wu, D., Ozaki, T., Yoshihara, Y., Kubo, N., & Nakagawara, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.402594 · Cited by 69

Coordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MAR element

Sinha, S., Malonia, S. K., Mittal, S. P. K., Singh, K., Sreenath, K., Kamat, R. H., Mukhopadhyaya, R., Pal, J. K., & Chattopadhyay, S. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.395 · Cited by 67

Structure of the Helicobacter pylori CagA oncoprotein bound to the human tumor suppressor ASPP2

Nes̆ić, D., Buti, L., Lü, X., & Stebbins, C. E. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320631111 · Cited by 67

ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia

Agirre, X., Román‐Gómez, J., Jiménez‐Velasco, A., Gárate, L., Montiel‐Duarte, C., Navarro, G., Vázquez, I., Zalacaín, M., Calasanz, M. J., Heiniger, A., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209236 · Cited by 67

Heat shock factor-1 modulates p53 activity in the transcriptional response to DNA damage

Logan, I. R., McNeill, H. V., Cook, S., Lü, X., Meek, D. W., Fuller-Pace, F. V., Lunec, J., & Robson, C. N. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp180 · Cited by 68

Wild type p53 reactivation: From lab bench to clinic

Selivanova, G. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.03.049 · Cited by 68

iASPP is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway

Chen, J., Xie, F., Zhang, L., & Jiang, W. G. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-694 · Cited by 64

A machine learning heuristic to identify biologically relevant and minimal biomarker panels from omics data

Swan, A., Stekel, D. J., Hodgman, C. T., Allaway, D., Al-Qahtani, M. H., Mobasheri, A., & Bacardit, J. (2015) · BMC Genomics · doi:10.1186/1471-2164-16-s1-s2 · Cited by 61

Implications of apoptosis regulators in tumorigenesis

Malaguarnera, L. (2004) · Cancer and Metastasis Reviews · doi:10.1023/b:canc.0000031774.32572.df · Cited by 61

ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells

Wang, Y., Godin-Heymann, N., WANG, X.-D., Bergamaschi, D., Llanos, S., & Lü, X. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.3 · Cited by 60

E2F1 death pathways as targets for cancer therapy

Pützer, B. M. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00030.x · Cited by 60

Dissecting functional roles of p53 N‐terminal transactivation domains by microarray expression analysis

Ohki, R., Kawase, T., Ohta, T., Ichikawa, H., & Taya, Y. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00375.x · Cited by 64

RASSF effectors couple diverse RAS subfamily GTPases to the Hippo pathway

Dhanaraman, T., Singh, S., Killoran, R. C., Singh, A., Xu, X., Shifman, J. M., & Smith, M. J. (2020) · Science Signaling · doi:10.1126/scisignal.abb4778 · Cited by 59

The dual role of p53: DNA protection and antioxidant

Borrás, C., Gómez‐Cabrera, M. C., & Viña, J. (2011) · Free Radical Research · doi:10.3109/10715762.2011.571685 · Cited by 58

Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene

Chen, D., Padiernos, E., Ding, F., Lossos, I. S., & Lopez, C. D. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401536 · Cited by 59

Role for Krüppel-Like Factor 4 in Determining the Outcome of p53 Response to DNA Damage

Zhou, Q., Yuan, H., Zhan, Q., Shen, Y., & Liu, Z. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1345 · Cited by 58

Differentiated embryo-chondrocyte expressed gene 1 regulates p53-dependent cell survival versus cell death through macrophage inhibitory cytokine-1

Qian, Y., Jung, Y.-S., & Chen, X. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203185109 · Cited by 59

P53 transcriptional activities: A general overview and some thoughts

Millau, J., Bastien, N., & Drouin, R. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.06.002 · Cited by 65

Tied Up in Loops: Positive and Negative Autoregulation of p53Preprint

Lü, X. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000984 · Cited by 58

N terminus of ASPP2 binds to Ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence

Wang, Z., Liu, Y., Takahashi, M., Hook, K. V., Kampa-Schittenhelm, K. M., Sheppard, B. C., Sears, R. C., Stork, P. A., & Lopez, C. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201514110 · Cited by 57

Chromatin Immunoprecipitation–on-Chip Reveals Stress-Dependent p53 Occupancy in Primary Normal Cells but Not in Established Cell Lines

Shaked, H., Shiff, I., Kott-Gutkowski, M., Siegfried, Z., Haupt, Y., & Simon, I. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0865 · Cited by 57

Unravelling mechanisms of cisplatin sensitivity and resistance in testicular cancer

Koster, R., van Vugt, M. A. T. M., Timmer‐Bosscha, H., Gietema, J. A., & de Jong, S. (2013) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2013.13 · Cited by 58

CagA–ASPP2 complex mediates loss of cell polarity and favors H. pylori colonization of human gastric organoids

Buti, L., Ruiz‐Puig, C., Sangberg, D., Leissing, T. M., Brewer, R. C., Owen, R. P., Sgromo, B., Royer, C., Ebner, D. V., & Lü, X. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908787117 · Cited by 60

ASPP1 and ASPP2 are new transcriptional targets of E2F

Fogal, V., Kartasheva, N. N., Trigiante, G., Llanos, S., Yap, D., Vousden, K. H., & Lü, X. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401562 · Cited by 57

Activation of p53 Function by Human Transcriptional Coactivator PC4: Role of Protein-Protein Interaction, DNA Bending, and Posttranslational Modifications

Batta, K., & Kundu, T. K. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01064-07 · Cited by 55

Testicular germ cell tumours: The paradigm of chemo-sensitive solid tumours

di Pietro, A., de Vries, E. G. E., Gietema, J. A., Spierings, D. C. J., & de Jong, S. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.06.014 · Cited by 57

The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization

Slee, E. A., Gillotin, S., Bergamaschi, D., Royer, C., Llanos, S., Ali, S., Jin, B., Trigiante, G., & Lü, X. (2004) · Oncogene · doi:10.1038/sj.onc.1208088 · Cited by 56

Splicing DNA-damage responses to tumour cell death

Crighton, D., & Ryan, K. M. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.09.001 · Cited by 56

Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73

Kawahara, M., Hori, T., Chonabayashi, K., Oka, T., Sudol, M., & Uchiyama, T. (2008) · Blood · doi:10.1182/blood-2007-09-111773 · Cited by 56

The recently discovered Apoptosis Stimulating Proteins of p53

Sullivan, A., & Lu, X. (2013)

ASPP: a new family of oncogenes and tumour suppressor genes

Sullivan, A., & Lü, X. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603525 · Cited by 215

ASPPs and cancer

Trigiante, G., & Lü, X. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1818 · Cited by 135

ASPP--Apoptotic specific regulator of p53.

Liu, Z.-J., Lu, X., & Zhong, S. (2005) · Biochimica et Biophysica Acta · doi:10.1016/j.bbcan.2005.08.002 · Cited by 26

ASPP1 and ASPP2: Common Activators of p53 Family Members

Bergamaschi, D., Samuels, Y., Jin, B., Duraisingham, S., Crook, T., & Lü, X. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1341-1350.2004 · Cited by 229